175 related articles for article (PubMed ID: 26121930)
1. (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.
Yu C; Pan D; Mi B; Xu Y; Lang L; Niu G; Yang M; Wan W; Chen X
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2021-8. PubMed ID: 26121930
[TBL] [Abstract][Full Text] [Related]
2. A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.
Gao S; Wu H; Li W; Zhao S; Teng X; Lu H; Hu X; Wang S; Yu J; Yuan S
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2029-37. PubMed ID: 26153145
[TBL] [Abstract][Full Text] [Related]
3. Radiation dosimetry estimates of (18)F-alfatide II based on whole-body PET imaging of mice.
Wang SY; Bao X; Wang MW; Zhang YP; Zhang YJ; Zhang JP
Appl Radiat Isot; 2015 Nov; 105():1-5. PubMed ID: 26218449
[TBL] [Abstract][Full Text] [Related]
4. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
[TBL] [Abstract][Full Text] [Related]
5. Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases.
Mi B; Yu C; Pan D; Yang M; Wan W; Niu G; Chen X
Theranostics; 2015; 5(10):1115-21. PubMed ID: 26199649
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
8. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
[TBL] [Abstract][Full Text] [Related]
9.
Wu J; Wang S; Zhang X; Teng Z; Wang J; Yung BC; Niu G; Zhu H; Lu G; Chen X
J Nucl Med; 2018 Dec; 59(12):1809-1816. PubMed ID: 29700127
[No Abstract] [Full Text] [Related]
10. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.
Wu C; Yue X; Lang L; Kiesewetter DO; Li F; Zhu Z; Niu G; Chen X
Theranostics; 2014; 4(5):546-55. PubMed ID: 24672585
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Wester HJ; Sell T; Bacher-Stier C; Fels L; Dinkelborg L; Schwaiger M
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1861-8. PubMed ID: 23877631
[TBL] [Abstract][Full Text] [Related]
14. Human biodistribution and radiation dosimetry of the demyelination tracer [
Brugarolas P; Wilks MQ; Noel J; Kaiser JA; Vesper DR; Ramos-Torres KM; Guehl NJ; Macdonald-Soccorso MT; Sun Y; Rice PA; Yokell DL; Lim R; Normandin MD; El Fakhri G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):344-351. PubMed ID: 36197499
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
Zhang J; Li D; Lang L; Zhu Z; Wang L; Wu P; Niu G; Li F; Chen X
J Nucl Med; 2016 Jan; 57(1):9-14. PubMed ID: 26449838
[TBL] [Abstract][Full Text] [Related]
16. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
Brody AL; Okita K; Shieh J; Liang L; Hubert R; Mamoun M; Farahi J; Mandelkern MA
Nucl Med Biol; 2014; 41(10):871-5. PubMed ID: 25156039
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis.
Kang F; Wang S; Tian F; Zhao M; Zhang M; Wang Z; Li G; Liu C; Yang W; Li X; Wang J
J Nucl Med; 2016 May; 57(5):672-7. PubMed ID: 26719378
[TBL] [Abstract][Full Text] [Related]
18. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Differential Diagnostic Values of
Du X; Zhang Y; Chen L; Mi B; You Q; Xu Y; Pan D; Wan W; Yang M; Yu C
Contrast Media Mol Imaging; 2018; 2018():8194678. PubMed ID: 29670497
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[
Yang Q; Zhu W; Ren C; Ji H; Wang D; Liu Y; Li F; Du Y; Liu Y; Huo L
Nucl Med Biol; 2021; 94-95():32-37. PubMed ID: 33486437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
